All data are based on the daily closing price as of December 24, 2024
c

Center Laboratories

4123.TWO
1.31 USD
0.02
+1.55%

Overview

Last close
1.31 usd
Market cap
941.75M usd
52 week high
1.77 usd
52 week low
1.25 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
20.215
Price/Book Value
1.5784
Enterprise Value
1.00B usd
EV/Revenue
20.8676
EV/EBITDA
-13.4142

Key financials

Revenue TTM
46.59M usd
Gross Profit TTM
7.94M usd
EBITDA TTM
9.58M usd
Earnings per Share
-0.02 usd
Dividend
N/A usd
Total assets
27.05B usd
Net debt
3.11B usd

About

Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass fibre pressure vessels. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei City
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top